Presence of metallo β-lactamases in imipenem-resistant Pseudomonas aeruginosa;Presencia de metalo-β-lactamasas en Pseudomonas aeruginosa resistente a imipenem

Revista Medica de Chile

Volumn 136, Issue 4, 2008, Pages 423-432

  Pérez I, Alfonso ^a   García C, Patricia ^b,f   Poggi M, Helena ^c   Braun J, Stephanie ^d   Castillo V, Claudia ^c   Román, Juan Carlos ^c   Lagos, Marcela ^b   Romeo O, Eliana ^c   Porte T, Lorena ^d   Labarca L, Jaime ^b   González R, Gerardo ^e  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d HOSPITAL MILITAR DE SANTIAGO   (Chile)

^e UNIVERSITY OF CONCEPCIÓN   (Chile)

^f Laboratorio de Biología Molecular   (Chile)

Author keywords

Beta lactamases; Imipenem; Pseudomonas aeruginosa

Indexed keywords

EID: 45849143327     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/s0034-98872008000400002     Document Type: Article

References (37)

1. GALES A, SADER H, JONES R. Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis 2002; 44: 301-11.
2. GALES A, SADER H, JONES R. SENTRY Participants Group (Latin America). Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000). Diagn Microbiol Infect Dis 2002; 44: 289-99.
3. SADER H, JONES R, SILVA J. SENTRY Participants Group (Latin America). Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns. Diagn Microbiol Infect Dis 2002; 44: 281-8.
4. SADER H, JONES R, ANDRADE-BAIOCCHI S, BIEDENBACH D. SENTRY Participants Group (Latin America). Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers. Diagn Microbiol Infect Dis 2002; 44: 273-80.
5. PARAMYTHIOTOU E, LUCET J, TIMSIT J, VANJAK D, PAUGAM-BURTZ C, TROUILLET J ET AL. Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity. Clin Infect Dis 2004; 38: 670-7.
6. TRUCCO O, PRADO V, DURÁN C, GRUPO PRONARES. Red de vigilancia de resistencia antimicrobiana PRONARES: Informe primer semestre 2001. Rev Chil Infect 2002; 19 Suppl 2: S140-8.
7. ZAMBRANO A, HERRERA N. Susceptibilidad antimicrobiana de cepas de Pseudomonas aeruginosa aisladas en el laboratorio del Hospital Regional Dr. Leonardo Guzmán de Antofagasta, Chile. Rev Chil Infect 2004; 21: 117-24.
8. GARCÍA P, CASTILLO C, VILLAGRA N, MELLA G, SALINAS AM, CANALES M, ET AL. Presencia de Metalo β Lactamasas en Pseudomonas aeruginosa resistente a carbapenémicos. CO-44, página 63 Libro de Resúmenes del XXI Congreso Chileno de Infectología. Octubre de 2004. Viña del Mar, Chile.
9. OKAMOTO K, GOTOH N, NISHINO T. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay. Antimicrob Agents Chemother 2001; 45: 1964-71.
10. LIVERMORE D. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 2002; 34: 634-40.
11. WALSH T, TOLEMAN M, POIREL L, NORDMANN P. Metallo-B-Lactamases: the Quiet before the Storm? Clin Microbiol Rev 2005; 18: 306-25.
12. TOLEMAN M, SIMM A, MURPHY T, GALES A, BIEDENBACH D, JONES R ET AL. Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. J Antimicrob Chemother 2002; 50: 673-9.
13. CASTANHEIRA M, TOLEMAN M, JONES R, SCHMIDT F, WALSH T. Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta- lactamase. Antimicrob Agents Chemother 2004; 48: 4654-61.
14. MENDES R, GARCÍA P, GUZMÁN M, TOLEMAN M, WALSH T, JONES R. First Isolation of blaVIM-2 in Latin America: Report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 2004; 48: 1433-4.
15. LINDEN P, KUSNE S, COLEY K, FONTES P, KRAMER D, PATERSON D. Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis 2003; 37: e154-60. Epub 2003 Oct 29.
16. FRITSCHE T, SADER H, TOLEMAN M, WALSH T, JONES R. Emerging Metallo-B-Lactamase-Mediated Resistance, A Summary Report from the Worldwide SENTRY Antimicrobial Surveillance Program. Clin Infect Dis 2005; 41 Suppl 4: S276-8.
17. VIM-2 in Pseudomonas aeruginosa Clinical Strains Isolated in Japan. Antimicrob Agents Chemother 2004; 48: 626-8.
18. ITO H, ARAKAWA Y, OHSUKA S, WACHAROTAYANKUN R, KATO N, OHTA M. Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens. Antimicrob Agents Chemother 1995; 39: 824-9.
19. MASLOW J, SLUTSKY A, ARBEIT R. Application of pulsed-field gel electrophoresis to molecular epidemiology. In: Persing DH, Smith TF, Tenover FC, White TJ. Diagnostic molecular microbiology: principles and applications. Washington, DC: American Society for Microbiology 1993: 563-72.
20. TENOVER F, ARBEIT R, GOERING R, MICKELSEN P, MURRAY B, PERSING D, SWAMINATHAN B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-9.
21. SPEIJER H, SAVELKOUL P, BONTEN M, STOBBERINNGH E, TJHIE J. Application of Different Genotyping Methods for Pseudomonas aeruginosa in a Setting of Endemicity in an Intensive Care Unit. J Clin Microbiol 1999; 37: 3654-61.
22. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility de test for bacteria that grow aerobically; Approved Standard-Sixth Edition. M7A6, Vol 23 (2): 12.
23. th Informational Supplement. Approved Standards M100-S15, Vol 25 (1).
24. JONES R, BARRY A, PACKER R, GREGORY W, THORNSBERRY C. In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination. J Clin Microbiol 1987; 25: 1725-9.
25. PATERSON D. The Epidemiological Profile of Infections with Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter Species. Clin Infect Dis 2006; 43 Suppl 2: S43-48.
26. FALAGAS M, KASIAKOU S. Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections. Clin Infect Dis 2005; 40: 1333-41.
27. PASTERAN F, FACCONE D, PETRONI A, RAPOPORT M, GALAS M, VÁZQUEZ M ET AL. Novel variant (bla(VIM-11)) of the metallo-{beta}-lactamase bla(VIM) family in a GES-1 extended-spectrum-B-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina. Antimicrob Agents Chemother 2005; 49: 474-5.
28. VILLEGAS M, LOLANS K, OLIVERA M, SUÁREZ J, CORREA A, QUEENAN A ET AL. First Detection of Metallo-B-Lactamase VIM-2 in Pseudomonas aeruginosa Isolates from Colombia. Antimicrob Agents Chemother 2004; 48: 4654-61.
29. VIM-2 Allele-Positive Clinical Isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2005; 43: 942-4.
30. WALSH T, BOLMSTRÖM A, QWÄRNSTRÖ M A, GALES A. Evaluation of a New Etest for Detecting Metallo-β-Lactamases in Routine Clinical Testing. J Clin Microbiol 2002; 40: 2755-9.
31. PITOUT, J, GREGSON D, POIREL L, MCCLURE J, LE P, CHURCH D. Detection Pseudomonas aeruginosa Producing Metallo-β-Lactamases in a Large Centralizad Laboratory. J Clin Microbiol 2005: 43; 3129-35.
32. YAN J, WU J, TSAI S, CHUANG C. Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-β-lactamases in gram-negative bacilli. Diagn Microbiol Infect Dis 2004: 49; 5-11.
33. BAXTER I, LAMBERT P. The effect of zinc on imipenem. Antimicrob Agents Chemother 1997; 39: 838-9.
34. CONEJO MC, GARCÍA I, MARTÍNEZ- MARTÍNEZ L, PICABEA L, PASCUAL A. Zinc Eluted from Siliconized Latex Urinary Catheters Decreases OprD Expression, Causing Carbapenem Resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2003: 47; 2313-5.
35. COLLIS C, HALL R. Expression of antibiotic resistance genes in the integrated cassettes of integrons. Antimicrob Agents Chemother 1995; 39: 155-62.
36. DOCQUIER J, LAMOTTE-BRASSEUR J, GALLENI M, AMICOSANTE G, FRERE J, ROSSOLINI G. On functional and structural heterogeneity of VIM-type metallo-beta- lactamases. J Antimicrob Chemother 2003; 51: 257-66.
37. NORDMANN P, POIREL L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 2002; 8: 321-31.